Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 3, 1998, Pages 411-420

  Miotla, Jadwiga M ^a,b   Teixeira, Mauro M ^a,c   Hellewell, Paul G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE;

2 PYRROLIDONE DERIVATIVE; 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; LIPOPOLYSACCHARIDE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; LUNG; LUNG CIRCULATION; MOUSE; NEUTROPHIL; NEWBORN; PATHOLOGY; TIME;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; NEUTROPHILS; PHOSPHODIESTERASE INHIBITORS; PULMONARY CIRCULATION; PYRROLIDINONES; RESPIRATORY DISTRESS SYNDROME, ADULT; ROLIPRAM; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 0032011545     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.3.2913     Document Type: Article

References (55)

1. Worthen, G. S., and G. P. Downey. 1996. Mechanisms of neutrophil mediated injury. In ARDS Acute Respiratory Distress in Adults. T. W. Evans and C. Haslett, editors. Chapman and Hall, London. 99-114.
2. Parsons, P., G. S. Worthen, E. Moir, R. Tate, and P. Henson. 1989. The association of circulating endotoxin with the development of ARDS. Am. Rev. Respir. Dis. 140:294-301.
3. Worthen, G. S., C. Haslett, A. J. Rees, R. S. Gumbay, J. E. Henson, and P. M. Henson. 1987. Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am. Rev. Respir. Dis. 136:19-28.
4. Kanazawa, M., A. Ishizaka, N. Hasegawa, Y. Suzuki, and T. Yokoyama. 1992. Granulocyte colony stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 145:1030-1035.
5. Olson, N. C., D. L. Anderson, and M. K. Grizzle. 1987. Dimethylthiourea attenuates endotoxin-induced acute respiratory failure in pigs. J. Appl. Physiol. 63:2426-2432.
6. Olson, N., M. Grizzle, and D. Anderson. 1987. Effect of polyethylene glycol-superoxide dismutase and catalase on endotoxemia in pigs. J. Appl. Physiol. 63:1526-1532.
7. Brigham, K., R. Bowers, and J. Haynes. 1979. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ. Res. 45:292-297.
8. Pober, J. S., M. A. Gimbrone, L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893-1896.
9. Osborn, L., C. Hession, R. Tizard, C. Cassallo, S. Luhowskyj, G. Chi-Rosso, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59:1203-1211.
10. Schleimer, R. P., and B. R. Rutledge. 1986. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulating with interleukin-1, endotoxin and tumor-promoting phorbol diesters. J. Immunol. 136:649-654.
11. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319-326.
12. Libby, P., J. M. Ordovas, K. R. Auger, A. H. Robbins, L. K. Birinyi, and C. A. Dinarello. 1986. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124:179-186.
13. Roten, R., M. Markert, F. Feihl, M. Schaller, M. Tagan, and C. Perret. 1991. Plasma levels of tumor necrosis factor in the ARDS. Am. Rev. Respir. Dis. 143:590-592.
14. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. Grau, and J. M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am. Rev. Respir. Dis. 145:1016-1621.
15. Marks, J. D., C. B. Marks, J. M. Luce, A. B. Montgomery, J. Turner, C. A. Metz, and J. F. Murray. 1990. Plasma tumor necrosis factor in patients with septic shock. Am. Rev. Respir. Dis. 141:94-97.
16. Stephens, K. E., A. Ishizaka, Z. Wu, J. W. Larrick, and T. A. Raffin. 1988. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 138:1300-1307.
17. Shalaby, M. R., B. B. Aggrawal, F., Rinderknecht, L. P. Svedersky, B. S. Finkle, and M. A. Palladino. 1985. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J. Immunol. 135:2069-2073.
18. Camussi, G., F. Bussolino, G. Salvido, and C. Baglioni. 1987. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils and vascular endothelium to synthesise and release platelet-activating factor. J. Exp. Med. 166:1390-1404.
19. Horvath, C., T. Ferro, G. Jesmok, and A. Malik. 1988. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc. Natl. Acad. Sci. USA 85:9219-9223.
20. Renz, H., J. Gong, A. Schmidt, M. Nain, and D. Gemsa. 1988. Release of tumor necrosis factor-α from macrophages: enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 141:2388-2393.
21. Scales, W., S. Chensue, I. Otterness, and S. Kunkel. 1989. Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin 1α or β-mRNA and cell-associated bioactivity. J. Leuk. Biol. 45:416-421.
22. Endres, S., H. Fulle, B. Sinha, D. Stoll, C. Dinarello, R. Gerzer, and P. Weber. 1991. Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-α and interleukin-1β by human mononuclear cells. Immunology 72:56-60.
23. Kunkel, S. L., D. G. Remick, R. M. Strieter, and J. W. Larrick. 1989. Mechanisms that regulate the production and effects of tumor necrosis factor-α Crit. Rev. Immunol. 9:93-117.
24. Beavo, J. A., and D. H. Reifsnyder. 1990. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11:150-155.
25. Lad, P. M. B. J. Goldberg, P. A. Smiley, and C. V. Olson. 1985. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. Biochim. Biophys. Acta 846:286-295.
26. Nielson, C. P., R. E. Vestal, R. J. Sturm, and R. Heaslip. 1990. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol. 86:801-808.
27. Wright, C. D., P. J. Kuipers, D. Kobylarz-Singer, L. J. Devall, B. A. Klinkefus, and R. E. Weishaar. 1990, Differential inhibition of human neutrophil functions: role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase. Biochem. Pharmacol. 40:699-707.
28. Lilly, C. M., J. S. Sandhu, A. Ishizaka, H. Harada, K. Yonemaru, J. W. Larrick, T. Shi, P. O'Hanley, and T. A. Raffin. 1988. Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am. Rev. Respir. Dis. 139:1361-1368.
29. Welsh, C. H., D. Lien, G. S. Worthen, and J. V. Weil. 1988. Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. Am. Rev. Respir. Dis. 138: 1106-1114.
30. Turner, C. R., K. M. Esser, and E. R. Wheeldon. 1943. Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition. Circ. Shock 39:237-245.
31. 2 integrin CD11b in mediating experimental lung injury in mice. Am. J. Respir. Crit. Care Med. 14:363-373.
32. Hunter, W. M., and F. C. Greenwood. 1962. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496.
33. Griswold, D. E., E. F. Webb, J. Breton, J. R. White, P. J. Marshall, and T. J. Torphy. 1993. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response. Inflammation 17:333-344.
34. Evans, T. J., D. Moyes, A. Carpenter, R. Martin, H. Loetscher, W. Lesslauer, and J. Cohen. 1994. Protective effect of 55- but not 75kD soluble tumor necrosis factor receptor-immunoglobulin G fusion protein in an animal model of gram-negative sepsis. J. Exp. Med. 180:2173-2179.
35. Suitters, A. J., R. Foulkes, S. M. Opal, J. E. Palardy, J. S. Emtage, M. Rolfe, S. Stephens, A. Morgan, A. R. Holt, L. C. Chaplin, N. E. Shaw, A. M. Nesbitt, and M. W. Bodmer. 1994. Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock. J. Exp. Med. 179:749-856.
36. Williams, F. M., M. Kus, K. Tanda, and T. J. Williams. 1994. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody, Br. J. Pharmacol. 111:1123-1128.
37. Espevik, T., and J. Nissen-Meyer. 1986. Highly sensitive cell line WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:299-305.
38. Baker, D., D. Butler, B. J. Scallon, J. K. O'Neill, J. L. Turk, and M. Feldmann. 1994. Control of established experimental allergic encephalomyelitis by inhibition of tumour necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobumin fusion proteins. Eur. J. Immunol. 24:2040-2048.
39. Miotla, J. M., P. K. Jeffery, and P. G. Hellewell. 1998. Platelet activating factor plays a pivotal role in the induction of experimental lung injury. Am. J. Respir. Cell Mol. Biol. 18:197-204.
40. Ishizaka, A., Z. Wu, K. E. Stephens, H. Harada, R. S. Hogue, P. T. O'Hanley, and T. A. Raffin. 1988. Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am. Rev. Respir. Dis. 138:376-382.
41. Sekut, L., J. A. Menius, M. F. Brackeen, and K. M. Connolly. 1994. Evaluation of the significance of elevated levels of systemic and localised tumor necrosis factor in different animal models of inflammation. J. Lab. Clin. Med. 124:813-820.
42. Pober, J. S., L. A. Lapierre, A. H. Stolpen, T. A. Brock, T. A. Springer, W. Fiers, M. P. Bevilacqua, D. L. Mendrick, and M. A. Grimbone. 1987. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparisons with tumor necrosis factor and interleukin 1 species. J. Immunol. 138:3319-3324.
43. Lo, S. K., P. A. Detmers, S. M. Levin, and S. D. Wright. 1989. Transient adhesion of neutrophils to endothelium. J. Exp. Med. 169:1779-1793.
44. Miotla, J. M., T. J. Williams, P. J. Jeffery, and P. G. Hellewell. 1994. A role for ICAM-1 in mediating neutrophil-induced increased pulmonary vascular permeability in the mouse. Am. Rev. Respir. Dis. 149:A1092. (Abstr.)
45. Remick, D. G., R. M. Strieter, M. K. Eskandari, D. T. Nguyen, M. A. Genord, C. L. Raiford, and S. L. Kunkel. 1990. Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 136:49-60.
46. Gatti, S., R. Faggioni, B. Echtenacher, and P. Ghezzi. 1993. Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin. Exp. Immunol. 91:456-461.
47. Pugin, J., B. Ricou, K. P. Steinberg, P. M. Suter, and T. R. Martin. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 153:1850-1856.
48. Pober, J. S., M. R. Slowik, L. G. De Luca, and A. J. Ritchie. 1993. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J. Immunol. 150:5114-5123.
49. Derian, C. K., R. J. Santulli, P. E. Rao, H. F. Solomon, and J. A. Barrett. 1995. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J. Immunol. 154:308-317.
50. Erzurum, S. C., G. P. Downey, D. E. Doherty, B. Schwab, E. L. Elson, and G. S. Worthen. 1992. Mechanisms of lipopolysaccharide-induced neutrophil retention: relative contributions of adhesive and cellular mechanical properties. J. Immunol. 149:154-162.
51. Downey, G. P., E. L. Elson, B. Schwab, S. C. Erzurum, S. K. Young, and G. S. Worthen. 1991. Biophysical properties and microfilament assembly in neutrophils: modulation by cyclic AMP. J. Cell Biol. 114:1179-1190.
52. Koga, S., S. Morris, S. Ogawa, H. Liao, J. P. Bilezikian, G. Chen, W. J. Thompson, T. Ashizaka, J. Brett, D. M. Stern, and D. J. Pinsky. 1995. TNF modulates endothelial properties by decreasing cAMP. Am. J. Physiol. 268:C1104-C1113.
53. Fonteh, A. N., J. D. Winkler, T. J. Torphy, J. Heravi, B. J. Undem, and F. H. Clinton. 1993. Influence of isopenterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil. J. Immunol. 151:339-350.
54. Pettipher, E. R., J. M. Labasi, E. D. Salter, E. J. Stam, J. B. Cheng, and R. J. Griffiths. 1996. Regulation ot tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram. Br. J. Pharmacol. 117:1530-1534.
55. Miotla, J. M., M. Perritti, R. J. Flower, P. J. Jeffery, and P. G. Hellewell. 1995. Suppression of experimental acute lung injury in the mouse by dexamethasone and the role of lipocortin-1. Br. J. Pharmacol. 114:248P.